SURVYR

DOCS

Doximity, Inc.
$33.63
−$0.62 (1.81%)Oct 29 close
Health CareS&P 400 CompareTechnicals
1M3M6M1Y2Y
-74%-52%-30%-8%+15%Oct 2025Oct 2026Apr 202652w high $71.3752w low $17.15
DOCSSPY
Wall St. Highest PT $47.00 (+39.8%) Wall St. Avg PT $31.11 (-7.5%)
$18$30$42$55$67POC $23Hi $47Avg $31
Underwater Drawdown %Max DD -73.1%Current -49.8%
0.0%-73.1%
Relative Strength vs SPY-62.6% vs SPYUnderperforming
+95%0%-95%
1W
−$0.05 (0.15%)
1M
+$7.11 (26.81%)
3M
+$12.39 (58.33%)
6M
+$9.19 (37.60%)
YTD
−$10.65 (24.05%)
1Y
−$33.14 (49.63%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street analyst consensus
SellHoldStrong Buy
Hold
18 analysts · mean score 2.62
1 = Strong Buy · 5 = Sell
Wall Street consensus
Analyst price targets
Current price$33.63
Average target$31.11
−$2.52 (−7.5%) downsideaverage target vs current price
CurrentAverageMedian
Low$18.00
Median$31.11
High$47.00
12-month Wall Street target range

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$6.0B
P/E (last 12 months)39.5
P/E (next 12 months, estimated)21.6
52-week range$17.15 – $71.37
Revenue growth (latest quarter vs a year ago)+7.3%
Dividend yieldNo dividend
Analyst consensusHold (18)
Average analyst price target$31.11 (-7%)

What they do

Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication.

Healthcare · Health Information Services
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

Momentum
2nd percentile in sector
F
12-1 return: -57.1%
Percentile within its GICS sector across the S&P 1500.
Growth
43rd percentile in sector
C
Revenue growth (YoY): +7.3%
Percentile within its GICS sector across the S&P 1500.
Value
32nd percentile in sector
D+
Forward E/P: 5.0% · EBITDA/EV: 4.3%
Percentile within its GICS sector across the S&P 1500.
Profitability
78th percentile in sector
B+
Profit margin: +25.5% · Return on equity: +17.2%
Percentile within its GICS sector across the S&P 1500.
Revisions
Not enough data yet
–
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
Outside this model's universe or screens
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
 SURVYR. Long Book
Not in the current book

Earnings & events

DOCS earningsNext report in 7 days
Next report · quarter Sep 2026
Thu Nov 5, 2026After the close
EPS consensus$0.35
Revenue consensus–
Last 4 quarters · EPS vs estimate
Aug 6, 2026$0.29est $0.30−4.2%Below estimates
May 13, 2026$0.26est $0.28−7.9%Below estimates
Feb 5, 2026$0.46est $0.45+2.9%Above estimates
Nov 6, 2025$0.45est $0.38+18.7%Above estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · report time: Nasdaq earnings calendar · refreshed 2026-10-27 18:16:12 ET
24-1125-0225-0525-0825-1126-0226-0526-080.000.46
EstimateActual (beat)Actual (miss)

News & catalysts

More news
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit
PR Newswire · Oct 26
INVESTOR NOTICE: Doximity, Inc. (NYSE: DOCS) Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before November 16, 2026 Deadline
PR Newswire · Oct 21
Doximity, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DOCS
PR Newswire · Oct 20
Insider trades
Sitaram Siddharth
Chief Accounting Officer · 2026-10-14
Sell
$80.2K
Wampler Kira Scherer
Director · 2026-10-01
Sell
$57.8K
Yang Watkin Phoebe L.
Director · 2026-09-30
Sell
$34.5K
Sitaram Siddharth
Chief Accounting Officer · 2026-09-15
Sell
$54.0K
Wampler Kira Scherer
Director · 2026-09-01
Sell
$52.7K
Wampler Kira Scherer
Director · 2026-08-25
Sell
$49.9K
Sitaram Siddharth
Chief Accounting Officer · 2026-08-13
Sell
$44.1K
Cabral Timothy S
Director · 2026-08-07
Sell
$293.3K
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–

Stats refreshed 2026-10-27 18:16:12 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026